Neuberger Berman High Yield Strategies Fund (NYSEAMERICAN:NHS) Stock Price Passes Below 200 Day Moving Average – Here’s Why

Neuberger Berman High Yield Strategies Fund (NYSEAMERICAN:NHSGet Free Report) shares passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $6.79 and traded as low as $6.11. Neuberger Berman High Yield Strategies Fund shares last traded at $6.12, with a volume of 68,514 shares.

Neuberger Berman High Yield Strategies Fund Trading Up 0.2%

The stock’s fifty day moving average is $6.24 and its 200 day moving average is $6.79.

Neuberger Berman High Yield Strategies Fund Dividend Announcement

The firm also recently declared a monthly dividend, which will be paid on Friday, July 31st. Shareholders of record on Wednesday, July 15th will be given a dividend of $0.0905 per share. The ex-dividend date of this dividend is Wednesday, July 15th. This represents a c) dividend on an annualized basis and a yield of 17.7%.

Institutional Investors Weigh In On Neuberger Berman High Yield Strategies Fund

Several institutional investors and hedge funds have recently modified their holdings of the stock. CoreCap Advisors LLC bought a new stake in shares of Neuberger Berman High Yield Strategies Fund during the 2nd quarter valued at $119,000. Mercer Global Advisors Inc. ADV grew its holdings in shares of Neuberger Berman High Yield Strategies Fund by 24.4% during the fourth quarter. Mercer Global Advisors Inc. ADV now owns 13,244 shares of the investment management company’s stock valued at $99,000 after buying an additional 2,597 shares during the last quarter. Guggenheim Capital LLC boosted its stake in Neuberger Berman High Yield Strategies Fund by 38.0% during the 4th quarter. Guggenheim Capital LLC now owns 567,943 shares of the investment management company’s stock valued at $4,225,000 after purchasing an additional 156,386 shares during the last quarter. Cetera Investment Advisers boosted its position in shares of Neuberger Berman High Yield Strategies Fund by 232.1% during the fourth quarter. Cetera Investment Advisers now owns 36,883 shares of the investment management company’s stock valued at $274,000 after buying an additional 25,777 shares during the last quarter. Finally, Osaic Holdings Inc. boosted its holdings in shares of Neuberger Berman High Yield Strategies Fund by 86.2% during the 4th quarter. Osaic Holdings Inc. now owns 74,294 shares of the investment management company’s stock valued at $553,000 after acquiring an additional 34,387 shares during the last quarter.

Neuberger Berman High Yield Strategies Fund Company Profile

(Get Free Report)

The Neuberger Berman High Yield Strategies Fund (NYSE American: NHS) is a closed-end, fixed-income management investment company focused on delivering high current income with the potential for capital appreciation. The fund primarily invests in below-investment-grade corporate debt—often referred to as high-yield bonds—issued by U.S. and select non-U.S. issuers. Through a diversified portfolio of high-yield instruments, NHS aims to provide enhanced yield relative to investment-grade alternatives.

Under its investment policy, NHS allocates the majority of its assets to corporate securities spanning sectors such as communications, energy, consumer goods, and industrials.

Featured Articles

Receive News & Ratings for Neuberger Berman High Yield Strategies Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neuberger Berman High Yield Strategies Fund and related companies with MarketBeat.com's FREE daily email newsletter.